These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 29739090)
21. The conglomeration of diagnostic, prognostic and therapeutic potential of serum miR-199a and its association with clinicopathological features in epithelial ovarian cancer. Zuberi M; Khan I; Gandhi G; Ray PC; Saxena A Tumour Biol; 2016 Aug; 37(8):11259-66. PubMed ID: 26951510 [TBL] [Abstract][Full Text] [Related]
22. MicroRNAs and metastasis-related gene expression in Egyptian breast cancer patients. Hafez MM; Hassan ZK; Zekri AR; Gaber AA; Al Rejaie SS; Sayed-Ahmed MM; Al Shabanah O Asian Pac J Cancer Prev; 2012; 13(2):591-8. PubMed ID: 22524830 [TBL] [Abstract][Full Text] [Related]
23. A panel of seven-miRNA signature in plasma as potential biomarker for colorectal cancer diagnosis. Zhang H; Zhu M; Shan X; Zhou X; Wang T; Zhang J; Tao J; Cheng W; Chen G; Li J; Liu P; Wang Q; Zhu W Gene; 2019 Mar; 687():246-254. PubMed ID: 30458288 [TBL] [Abstract][Full Text] [Related]
24. Decreased Expression of Bioinformatically Predicted piwil2-targetting microRNAs, miR-1267 and miR-2276 in Breast Cancer. Torkashvand S; Damavandi Z; Mirzaei B; Tavallaei M; Vasei M; Mowla SJ Arch Iran Med; 2016 Jun; 19(6):420-5. PubMed ID: 27293058 [TBL] [Abstract][Full Text] [Related]
25. MicroRNA-451 as a prognostic marker for diagnosis and lymph node metastasis of papillary thyroid carcinoma. Zhang M; Wu W; Gao M; Fei Z Cancer Biomark; 2017 Jul; 19(4):437-445. PubMed ID: 28582849 [TBL] [Abstract][Full Text] [Related]
26. Identification of serum miR-1915-3p and miR-455-3p as biomarkers for breast cancer. Guo J; Liu C; Wang W; Liu Y; He H; Chen C; Xiang R; Luo Y PLoS One; 2018; 13(7):e0200716. PubMed ID: 30048472 [TBL] [Abstract][Full Text] [Related]
27. miR-629-3p may serve as a novel biomarker and potential therapeutic target for lung metastases of triple-negative breast cancer. Wang J; Song C; Tang H; Zhang C; Tang J; Li X; Chen B; Xie X Breast Cancer Res; 2017 Jun; 19(1):72. PubMed ID: 28629464 [TBL] [Abstract][Full Text] [Related]
28. Expression levels of miR-143-3p and -424-5p in colorectal cancer and their clinical significance. Sahami-Fard MH; Kheirandish S; Sheikhha MH Cancer Biomark; 2019; 24(3):291-297. PubMed ID: 30883340 [TBL] [Abstract][Full Text] [Related]
29. Serum microRNA-221 functions as a potential diagnostic and prognostic marker for patients with osteosarcoma. Yang Z; Zhang Y; Zhang X; Zhang M; Liu H; Zhang S; Qi B; Sun X Biomed Pharmacother; 2015 Oct; 75():153-8. PubMed ID: 26422796 [TBL] [Abstract][Full Text] [Related]
30. MicroRNA-9 as potential biomarker for breast cancer local recurrence and tumor estrogen receptor status. Zhou X; Marian C; Makambi KH; Kosti O; Kallakury BV; Loffredo CA; Zheng YL PLoS One; 2012; 7(6):e39011. PubMed ID: 22723919 [TBL] [Abstract][Full Text] [Related]
31. A nine-miRNA signature as a potential diagnostic marker for breast carcinoma: An integrated study of 1,110 cases. Xiong DD; Lv J; Wei KL; Feng ZB; Chen JT; Liu KC; Chen G; Luo DZ Oncol Rep; 2017 Jun; 37(6):3297-3304. PubMed ID: 28440475 [TBL] [Abstract][Full Text] [Related]
32. High miR-96 levels in colorectal adenocarcinoma predict poor prognosis, particularly in patients without distant metastasis at the time of initial diagnosis. Rapti SM; Kontos CK; Papadopoulos IN; Scorilas A Tumour Biol; 2016 Sep; 37(9):11815-11824. PubMed ID: 27044381 [TBL] [Abstract][Full Text] [Related]
33. Identification of microRNA biomarkers in the blood of breast cancer patients based on microRNA profiling. Zhang K; Wang YW; Wang YY; Song Y; Zhu J; Si PC; Ma R Gene; 2017 Jul; 619():10-20. PubMed ID: 28359916 [TBL] [Abstract][Full Text] [Related]
34. DNA methylation contributes to deregulation of 12 cancer-associated microRNAs and breast cancer progression. Pronina IV; Loginov VI; Burdennyy AM; Fridman MV; Senchenko VN; Kazubskaya TP; Kushlinskii NE; Dmitriev AA; Braga EA Gene; 2017 Mar; 604():1-8. PubMed ID: 27998789 [TBL] [Abstract][Full Text] [Related]
35. Serum miR-182 and miR-331-3p as diagnostic and prognostic markers in patients with hepatocellular carcinoma. Chen L; Chu F; Cao Y; Shao J; Wang F Tumour Biol; 2015 Sep; 36(10):7439-47. PubMed ID: 25903466 [TBL] [Abstract][Full Text] [Related]
36. DNA methylation mediated silencing of microRNA-874 is a promising diagnosis and prognostic marker in breast cancer. Zhang L; Yan DL; Yang F; Wang DD; Chen X; Wu JZ; Tang JH; Xia WJ Oncotarget; 2017 Jul; 8(28):45496-45505. PubMed ID: 28525377 [TBL] [Abstract][Full Text] [Related]
37. Role of miR-139 as a surrogate marker for tumor aggression in breast cancer. Dai H; Gallagher D; Schmitt S; Pessetto ZY; Fan F; Godwin AK; Tawfik O Hum Pathol; 2017 Mar; 61():68-77. PubMed ID: 27864119 [TBL] [Abstract][Full Text] [Related]
38. Prognostic and biological significance of microRNA-221 in breast cancer. Eissa S; Matboli M; Sharawy A; El-Sharkawi F Gene; 2015 Dec; 574(1):163-7. PubMed ID: 26253160 [TBL] [Abstract][Full Text] [Related]
39. miR-105/93-3p promotes chemoresistance and circulating miR-105/93-3p acts as a diagnostic biomarker for triple negative breast cancer. Li HY; Liang JL; Kuo YL; Lee HH; Calkins MJ; Chang HT; Lin FC; Chen YC; Hsu TI; Hsiao M; Ger LP; Lu PJ Breast Cancer Res; 2017 Dec; 19(1):133. PubMed ID: 29258605 [TBL] [Abstract][Full Text] [Related]
40. Study on the relationship between miR-520g and the development of breast cancer. Ren GB; Wang L; Zhang FH; Meng XR; Mao ZP Eur Rev Med Pharmacol Sci; 2016; 20(4):657-63. PubMed ID: 26957267 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]